創勝集團-B(06628)於ESMO 2024年會公佈OSEMITAMAB (TST001)三聯療法一線治療胃或胃食管結合部腺癌令人鼓舞的療效數據

Post Content

Read More 

You may also like...

Generated by Feedzy